NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.85 +0.83 (+1.06%) GOLD FUTURES
2,393.60 +33.70 (+1.43%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
52,117.06 +3,558.48 (+7.33%)
ChemoMetec A/S (0DZ0.L)
| Previous close | 778.50 |
| Open | 791.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 791.00 - 810.50 |
| 52-week range | 304.00 - 905.00 |
| Volume | |
| Avg. volume | 5,187 |
| Market cap | 120.703M |
| Beta (5Y monthly) | 1.26 |
| PE ratio (TTM) | 1.09 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Globe Newswire
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 266 Major shareholder announcement Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on 13 May 2024, decreased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to below 10%, and that the holding thus is below the 10 per cent limit in section 38 of the Capital Markets Act. The
- GlobeNewswire
Notification of managers’ transactions
ANNOUNCEMENT NO. 265 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them. See the transactions of member of the Board of Directors Peter Reich in the attached PDF document. For further information, please contact: Niels Høy Nielsen, CFO
- Globe Newswire
Q3 2023/24 - First sale of the XM30 completed
ANNOUNCEMENT NO. 262 Trading statement for Q3 2023/24 (1 January - 31 March 2024) First sale of the XM30 completed Revenue declined by 6% in the third quarter of 2023/24 to DKK 98.9 million from DKK 105.4 million in the year-earlier period. The development reflected continued growth in sales of consumables and services, set off by declining sales of instruments as customers continued to show restraint in purchasing new instruments. EBITDA fell to DKK 43.1 million in the third quarter, being affe
